Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 27, 2026
TELEFLEX INC (TFX)
A forensic read on TELEFLEX INC built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
3.6
Altman Z-score
Clean
Earnings quality
4
Forensic signals
-28.3%
ROE
$5.7B
Market cap
1.12%
Dividend yield
TELEFLEX INC earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 3.6, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by receivables vs revenue.
What the filings flag
63d DSOReceivables vs revenue.Days sales outstanding moved from 49 to 63 days FY2024→FY2025 (receivables +52% vs revenue +17%). Receivables are outrunning sales — a flag for aggressive revenue recognition or slipping collections.
2%Return on invested capital.Return on invested capital is 2% and slipping from 7% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
$240MGoodwill impairments.Took $240M of goodwill writedowns across 1 year(s) (FY2024 ($240M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
-5%Dividend — cut.The payout was CUT ~5% in FY2025 (from FY2024). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies — weigh the cut when judging reliability.
Key fundamentals
Net Margin-45.4%
Debt / Equity0.85x
Latest Revenue$1.99B
Return on Equity-29.0%
Revenue Growth YoY+17.2%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on TELEFLEX INC:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about TFX's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown